-
Product Insights
NewNovoCure Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our NovoCure Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. NovoCure Ltd (NovoCure) is focused on the development and commercialization of novel delivery systems for the treatment of cancers of brain, thoracic and abdomen. Its proprietary Tumor Treating Fields (TTF) technology platform uses electric fields tuned to specific frequencies for disrupting the division of solid tumor cancer cells. The company markets TTF-based delivery systems: Optune Lua for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NGN-401 in Rett Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NGN-401 in Rett Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NGN-401 in Rett Syndrome Drug Details: NGN-401 is under development for the...
-
Product Insights
NewHearing Aid Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Hearing Aid Devices Pipeline Market Report Overview Hearing aid devices are the electronic device that amplifies and transmits sound, used by people with impaired hearing. The hearing aid devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials....
-
Sector Analysis
NewAutomotive Aftermarket Size, Trends and Analysis by Region, Component, Product Family, Channel and Segment Forecast to 2028
Accessing the in-depth insights from the ‘Automotive Aftermarket’ report can help: Gain a valuable understanding of the current and future state of the market, allowing businesses to make informed decisions about market entry, product development, and investments. Identify competitors' capabilities to stay ahead in the market. Identify segments and get an understanding of various stakeholders across different stages of the entire value chain. Anticipate changes in demand and adjust the business development strategies. Identify potential regions and countries for growth opportunities. How is our ‘Automotive...
-
Sector Analysis
Enterprise IoT Market Trends and Analysis by Region, Product, Enterprise, Vertical, Connectivity and Segment Forecast to 2027
Accessing the in-depth insights from the ‘Enterprise IoT report can help: Gain a valuable understanding of the current and future state of the market, allowing businesses to make informed decisions about market entry, product development, and investments Identify competitors' capabilities to stay ahead in the market Identify segments and get an understanding of various stakeholders across different stages of the entire value chain Anticipate changes in demand and adjust the business development strategies Identify potential regions and countries for growth opportunities How is our ‘Enterprise...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NGN-401 in Rett Syndrome
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. NGN-401 in Rett Syndrome Drug Details: NGN-401 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PY-159 in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PY-159 in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PY-159 in Triple-Negative Breast Cancer (TNBC) Drug Details: PY-159 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PY-159 in Lung Adenocarcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PY-159 in Lung Adenocarcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PY-159 in Lung Adenocarcinoma Drug Details: PY-159 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PY-159 in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PY-159 in Colorectal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PY-159 in Colorectal Cancer Drug Details: PY-159 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PY-159 in Fallopian Tube Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PY-159 in Fallopian Tube Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PY-159 in Fallopian Tube Cancer Drug Details: PY-159 is under development...